Total Payments
$55,012
2024 Payments
$3,353
Companies
51
Transactions
1,083
Medicare Patients
16,309
Medicare Billing
$893,729
Payment Breakdown by Category
Other$38,700 (70.3%)
Food & Beverage$15,825 (28.8%)
Education$486.10 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $38,700 | 15 | 70.3% |
| Food and Beverage | $15,825 | 1,060 | 28.8% |
| Education | $486.10 | 8 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $43,081 | 324 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,060 | 99 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,427 | 108 | $0 (2024) |
| Grifols USA, LLC | $814.11 | 96 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $728.04 | 37 | $0 (2024) |
| PFIZER INC. | $531.82 | 41 | $0 (2024) |
| GENZYME CORPORATION | $494.56 | 32 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $401.73 | 25 | $0 (2023) |
| JAZZ PHARMACEUTICALS INC. | $357.12 | 13 | $0 (2024) |
| Insmed, Inc. | $356.13 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,353 | 150 | GlaxoSmithKline, LLC. ($1,449) |
| 2023 | $15,789 | 142 | GlaxoSmithKline, LLC. ($13,782) |
| 2022 | $11,560 | 130 | GlaxoSmithKline, LLC. ($9,775) |
| 2021 | $15,112 | 151 | GlaxoSmithKline, LLC. ($13,485) |
| 2020 | $4,229 | 123 | GlaxoSmithKline, LLC. ($2,927) |
| 2019 | $1,960 | 127 | GlaxoSmithKline, LLC. ($880.80) |
| 2018 | $1,708 | 142 | GlaxoSmithKline, LLC. ($531.71) |
| 2017 | $1,302 | 118 | GlaxoSmithKline, LLC. ($251.13) |
All Payment Transactions
1,083 individual payment records from CMS Open Payments — Page 1 of 44
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Immunology | ||||||
| 12/09/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $10.24 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $8.56 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: ANTIBIOTIC | ||||||
| 12/02/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: IMMUNOLOGY | ||||||
| 11/27/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $38.51 | General |
| Category: NEUROLOGY | ||||||
| 11/25/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/20/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: Immunology | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $12.92 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $8.18 | General |
| Category: Narcoplepsy | ||||||
| 11/18/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $0.88 | General |
| Category: Narcoplepsy | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | Octapharma USA, Inc. | CUTAQUIG (Biological) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $9.95 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: Respiratory | ||||||
| 11/07/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: RESPIRATORY | ||||||
| 11/07/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $0.66 | General |
| Category: RESPIRATORY | ||||||
| 11/06/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: Pulmonology | ||||||
| 10/30/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: Respiratory | ||||||
| 10/28/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: Immunology | ||||||
| 10/28/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $9.30 | General |
| Category: Narcoplepsy | ||||||
| 10/28/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $1.10 | General |
| Category: Narcoplepsy | ||||||
| 10/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $25.78 | General |
| 10/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $1.33 | General |
| Category: RESPIRATORY | ||||||
| 10/23/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 33 | 3,950 | 5,494 | $552,067 | $232,893 |
| 2022 | 34 | 3,934 | 5,902 | $519,227 | $229,492 |
| 2021 | 34 | 4,207 | 5,918 | $518,768 | $239,117 |
| 2020 | 36 | 4,218 | 5,626 | $428,555 | $192,227 |
Total Patients
16,309
Total Services
22,940
Medicare Billing
$893,729
Procedure Codes
137
All Medicare Procedures & Services
137 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 581 | 1,463 | $234,430 | $131,271 | 56.0% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 818 | 1,029 | $107,016 | $23,492 | 22.0% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 328 | 347 | $32,965 | $13,820 | 41.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 135 | 135 | $10,770 | $9,711 | 90.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 72 | 72 | $15,120 | $8,255 | 54.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 27 | 27 | $8,370 | $7,628 | 91.1% |
| 94375 | Test to measure rate of airflow | Office | 2023 | 247 | 258 | $23,478 | $7,006 | 29.8% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 124 | 125 | $11,875 | $4,507 | 38.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 138 | 138 | $4,830 | $3,951 | 81.8% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 157 | 164 | $49,200 | $3,885 | 7.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 357 | 459 | $5,508 | $3,856 | 70.0% |
| 83880 | Natriuretic peptide (heart and blood vessel protein) level | Office | 2023 | 31 | 52 | $2,340 | $2,000 | 85.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 91 | 202 | $7,070 | $1,925 | 27.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 31 | 33 | $4,290 | $1,832 | 42.7% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 58 | 58 | $10,150 | $1,565 | 15.4% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 86 | 164 | $2,460 | $1,390 | 56.5% |
| 74019 | X-ray of abdomen, 2 views | Office | 2023 | 37 | 37 | $3,597 | $900.04 | 25.0% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 65 | 93 | $2,790 | $770.97 | 27.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 26 | 26 | $910.00 | $744.38 | 81.8% |
| 85018 | Blood count, hemoglobin | Office | 2023 | 282 | 297 | $2,970 | $689.04 | 23.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 74 | 89 | $2,314 | $677.29 | 29.3% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 12 | 13 | $1,092 | $450.06 | 41.2% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 11 | 24 | $1,080 | $389.28 | 36.0% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 22 | 23 | $598.00 | $378.58 | 63.3% |
| 80076 | Liver function blood test panel | Office | 2023 | 32 | 41 | $1,230 | $328.41 | 26.7% |
About Dr. Robert Daly, MD
Dr. Robert Daly, MD is a Pulmonary Disease healthcare provider based in Greenwood, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1255311981.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Daly, MD has received a total of $55,012 in payments from pharmaceutical and medical device companies, with $3,353 received in 2024. These payments were reported across 1,083 transactions from 51 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($38,700).
As a Medicare-enrolled provider, Daly has provided services to 16,309 Medicare beneficiaries, totaling 22,940 services with total Medicare billing of $893,729. Data is available for 4 years (2020–2023), covering 137 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Greenwood, IN
- Active Since 01/19/2006
- Last Updated 01/13/2022
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1255311981
Products in Payments
- TRELEGY ELLIPTA (Drug) $19,363
- ANORO ELLIPTA (Drug) $3,724
- NUCALA (Biological) $2,125
- DUPIXENT (Biological) $1,308
- OFEV (Drug) $912.91
- Prolastin-C Liquid (Biological) $614.32
- ELIQUIS (Drug) $455.80
- GLASSIA (Biological) $377.53
- BREZTRI (Drug) $362.36
- FASENRA (Biological) $358.24
- Arikayce (Drug) $356.13
- STIOLTO RESPIMAT (Drug) $351.38
- XOLAIR (Biological) $343.45
- TEZSPIRE (Biological) $330.93
- ANORO (Drug) $272.50
- SMARTVEST (Device) $255.79
- XYWAV (Drug) $237.54
- Prolastin-C (Biological) $179.80
- AIRSUPRA (Drug) $179.34
- Hizentra (Biological) $168.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.